V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300008114 | 300004964 | 1.62 | 77 | Disease modification (D) | null | 2018-07-08 | CAPECITABINE + OXALIPLATIN | N | N | 300024361 | IRINOTECAN + MDG |
| 300008115 | 300004975 | 1.85 | 62.9 | Palliative (P) | 2015-05-29 | 2015-06-14 | CISPLATIN + FLUOROURACIL | N | N | 300024529 | IRINOTECAN + MDG |
| 300008116 | 300004983 | 1.87 | 66.1 | Neo-adjuvant (N) | null | 2018-12-06 | CETUXIMAB | null | null | 300024724 | TRIAL |
| 300008117 | 300004990 | null | 84 | Curative (C) | null | 2017-11-29 | Cetuximab + Radiotherapy Maint | 01 | Y | 300024788 | CETUXIMAB + RT |
| 300008118 | 300004996 | 1.71 | 75 | Adjuvant (A) | 2016-01-05 | 2016-02-02 | Carboplatin + Vinorelbine Oral | 2 | N | 300024838 | TOPOTECAN |
| 300008119 | 300007835 | null | 52.6 | Adjuvant (A) | 2015-11-27 | 2015-12-25 | Cisplatin 7 day | N | null | 300024858 | CISPLATIN + FLUOROURACIL |
| 300008120 | 300004999 | 1.73 | 65.9 | Palliative (P) | 2016-03-08 | 2016-04-09 | Cisplatin | N | N | 300024875 | CHOP R |
| 300008122 | 300005005 | null | null | null | 2016-07-16 | 2016-07-16 | Carboplatin AUC 6 - 10 | 02 | null | 300024887 | CARBOPLATIN |
| 300008123 | 300005006 | 1.63 | null | null | null | 2018-06-02 | CAP + RT | N | Y | 300024921 | CARBOPLATIN |
| 300008124 | 300005012 | 1.81 | 66 | Palliative (P) | 2016-09-21 | 2016-09-28 | Cisplatin | 02 | null | 300024966 | OXALIPLATIN + MDG |
| 300008125 | 300008283 | 1.57 | 43.6 | Palliative (P) | 2017-11-25 | 2018-02-18 | Cisplatin 7 day | N | null | 300025042 | OXALIPLATIN |
| 300008128 | 300005045 | 1.67 | 52.75 | Palliative (P) | 2015-04-19 | 2015-04-23 | Trial Unspecified | N | null | 300025342 | CARBOPLATIN + ETOPOSIDE |
| 300008129 | 300005052 | 1.67 | 53.8 | Palliative (P) | 2015-10-12 | 2015-11-25 | Carboplatin + Liposomal Doxorubicin | 2 | N | 300025458 | TRIAL |
| 300008130 | 300005057 | 1.7 | 95 | Palliative (P) | 2016-04-30 | 2016-07-16 | Oxaliplatin + Modified de Gramont | N | Y | 300025465 | CETUXIMAB |
| 300008132 | 300005059 | 1.72 | 71.8 | Curative (C) | null | 2014-09-09 | Trial Unspecified | N | null | 300025504 | CETUXIMAB |
| 300008133 | 300005076 | 1.81 | null | Palliative (P) | 2015-03-15 | 2015-03-19 | Oxaliplatin + Modified de Gramont | N | N | 300025753 | CARBOPLATIN + LIPOSOMAL DOX |
| 300008134 | 300005078 | 1.53 | null | Curative (C) | 2014-03-17 | 2015-02-16 | CISPLATIN + FLUOROURACIL | N | N | 300025764 | CARBOPLATIN + ETOPOSIDE |
| 300008135 | 300005079 | 1.67 | 45.2 | Palliative (P) | 2016-04-01 | 2017-05-05 | PACLITAXEL | N | N | 300025775 | CETUXIMAB |
| 300008137 | 300005091 | null | 58.8 | null | 2016-08-24 | 2016-09-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | 300025947 | CARBOPLATIN + ETOPOSIDE |
| 300008138 | 300005093 | 1.58 | 58 | Palliative (P) | 2014-11-28 | 2014-12-23 | CISPLATIN + FLUOROURACIL | 2 | N | 300025949 | CISPLATIN + FLUOROURACIL |
| 300008139 | 300005095 | 1.64 | 94.1 | Curative (C) | 2014-07-02 | 2014-07-23 | CARBOPLATIN | 02 | Y | 300025959 | CISPLATIN |
| 300008140 | 300005100 | null | 84.3 | null | 2017-02-28 | 2017-03-06 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300026039 | OXALIPLATIN |
| 300008141 | 300005112 | 1.58 | 51.5 | Neo-adjuvant (N) | 2014-06-11 | 2014-06-11 | Oxaliplatin + Modified de Gramont | 2 | N | 300026170 | CAPECITABINE + OXALIPLATIN |
| 300008142 | 300007133 | null | 64.9 | null | 2016-03-23 | 2017-01-11 | Gemcitabine + RT pancreas | 02 | null | 300026264 | CETUXIMAB |
| 300008143 | 300005122 | null | null | Palliative (P) | 2017-05-10 | 2017-05-12 | Trial Unspecified | 02 | null | 300026280 | CISPLATIN + FLUOROURACIL |
| 300008144 | 300005127 | 1.64 | 69.3 | Palliative (P) | 2011-03-19 | 2014-10-31 | Gemcitabine + RT pancreas | N | Y | 300026338 | CETUXIMAB |
| 300008145 | 300005134 | null | 79.5 | null | 2018-09-26 | 2018-09-27 | IGEV R | N | null | 300001159 | CAPECITABINE + GEMCITABINE |
| 300008146 | 300005141 | 1.78 | 64 | Palliative (P) | 2018-05-08 | 2018-05-27 | Cetuximab + Radiotherapy Maint | 02 | Y | 300001503 | CARBOPLATIN + RT |
| 300008147 | 300005144 | 1.68 | 65.2 | Palliative (P) | null | 2016-11-03 | Cetuximab 7 day (>Cycle 2) | N | N | 300001862 | TRIAL |
| 300008148 | 300005146 | 1.7 | null | Disease modification (D) | 2019-03-08 | 2019-05-14 | Trial Unspecified | N | N | 300002653 | NIVOLUMAB |
| 300008149 | 300005149 | null | null | Palliative (P) | 2018-08-28 | 2018-08-30 | Capecitabine | N | null | 300003293 | OXALIPLATIN + MDG |
| 300008150 | 300005157 | 1.64 | 67 | Palliative (P) | 2018-01-31 | 2018-02-23 | CARBOPLATIN + FLUOROURACIL | 02 | N | 300003661 | CISPLATIN + FLUOROURACIL |
| 300008151 | 300005157 | 1.67 | 55.8 | Palliative (P) | 2018-04-08 | 2018-06-25 | Capecitabine | N | N | 300003661 | CAPECITABINE |
| 300008152 | 300005167 | 1.58 | 85.5 | Palliative (P) | 2017-12-06 | 2017-12-16 | Cyclophosphamide + Docetaxel | 2 | N | 300005518 | CISPLATIN |
| 300008153 | 300005171 | 1.74 | 53.7 | Palliative (P) | 2018-10-02 | 2018-12-16 | OXALIPLATIN | null | null | 300006208 | TRIAL |
| 300008154 | 300005175 | null | null | Disease modification (D) | 2018-03-27 | 2018-05-11 | Gemcitabine + Capecitabine | 02 | null | 300006487 | CETUXIMAB |
| 300008155 | 300005185 | 1.82 | 71.8 | Palliative (P) | 2016-04-21 | 2016-06-09 | Cetuximab + Radiotherapy Maint | N | Y | 300008609 | CARBOPLATIN |
| 300008156 | 300005204 | 1.69 | 57.55 | null | 2018-10-16 | 2018-11-29 | Cisplatin 7 day | N | Y | 300011708 | CETUXIMAB |
| 300008157 | 300005207 | null | 0 | Disease modification (D) | 2019-03-03 | 2019-03-29 | CARBOPLATIN + PACLITAXEL | 02 | N | 300011918 | DOCETAXEL |
| 300008158 | 300005211 | null | 57.55 | Palliative (P) | 2018-04-20 | 2018-05-08 | Trial Unspecified | 02 | N | 300012874 | OXALIPLATIN + MDG |
| 300008159 | 300005213 | 1.63 | 54.8 | Palliative (P) | 2016-04-18 | 2016-05-09 | Carboplatin + Paclitaxel (weekly) | 02 | N | 300014246 | CISPLATIN + FLUOROURACIL + RT |
| 300008160 | 300005218 | 1.86 | 111 | Palliative (P) | 2017-12-04 | 2017-12-09 | Trial Unspecified | N | N | 300015601 | CETUXIMAB |
| 300008161 | 300008289 | 1.6 | 66.1 | Palliative (P) | 2017-07-04 | 2017-07-04 | CISPLATIN + FLUOROURACIL | 02 | N | 300017755 | CARBOPLATIN + PEMETREXED |
| 300008162 | 300005222 | null | 45.7 | Palliative (P) | 2015-06-30 | 2015-07-01 | Cetuximab + Radiotherapy Maint | N | Y | 300019303 | CARBOPLATIN + CETUXIMAB + FU |
| 300008163 | 300005229 | 1.76 | 58.4 | Curative (C) | 2019-03-20 | 2019-04-10 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300021811 | GEMCARBO |
| 300008164 | 300007874 | 1.71 | 94.15 | null | null | 2014-12-17 | CARBOPLATIN + RT | null | null | 300022536 | OXALIPLATIN + MDG |
| 300008165 | 300005236 | 1.58 | 57 | Palliative (P) | 2016-07-29 | 2016-08-04 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 300024122 | CARBO + FLUOROURACIL |
| 300008166 | 300008290 | null | 69 | Palliative (P) | 2015-05-05 | 2015-05-07 | Dasatinib | 01 | N | 300024690 | NOT MATCHED |
| 300008167 | 300005249 | null | 85.3 | Palliative (P) | 2018-12-11 | 2018-12-21 | CISPLATIN + FLUOROURACIL | N | Y | 300006118 | CETUXIMAB + RT |
| 300008168 | 300003568 | 1.69 | 58.3 | null | 2014-05-30 | 2014-06-06 | Gemcitabine 1000mg/m2 D1 8 15 | N | Y | 300000380 | GEMCITABINE |